$GEHC

GE HealthCare Technologies Inc.

CIK:0001932393|SEC Filings

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Total revenues	$ 5,295	$ 5,007	$ 10,425	$ 9,784
Gross profit	2,180	1,985	4,157	3,997
Selling, general, and administrative	1,118	1,029	2,235	2,069
Research and development	323	302	668	646
Total operating expenses	1,441	1,331	2,903	2,714
Operating income	739	654	1,254	1,283
Interest and other financial charges – net	114	113	210	224
Non-operating benefit (income) costs	(45)	(73)	(96)	(148)
Other (income) expense – net	(22)	1	(58)	(98)
Income before income taxes	693	613	1,198	1,304
Benefit (provision) for income taxes	(119)	(113)	(213)	(216)
Net income	573	500	985	1,088
Net (income) loss attributable to noncontrolling interests	(13)	(14)	(35)	(39)
Net income attributable to GE HealthCare	$ 561	$ 486	$ 950	$ 1,049
Earnings per share attributable to GE HealthCare:
Basic (in dollars per share)	$ 1.24	$ 1.06	$ 2.09	$ 2.30
Diluted (in dollars per share)	$ 1.24	$ 1.06	$ 2.08	$ 2.29
Weighted-average number of shares outstanding:
Basic (in shares)	453	457	454	457
Diluted (in shares)	454	458	456	459
Product
Total revenues	$ 3,416	$ 3,263	$ 6,762	$ 6,380
Cost of revenue	2,217	2,160	4,500	4,122
Service
Total revenues	1,878	1,743	3,664	3,404
Cost of revenue	$ 898	$ 863	$ 1,769	$ 1,665

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows - operating activities
Net income	$ 985	$ 1,088
Adjustments to reconcile Net income to Cash from (used for) operating activities:
Depreciation of property, plant, and equipment	154	138
Amortization of intangible assets	159	146
Gain on remeasurement of Nihon Medi-Physics equity method investment	0	(97)
Net periodic postretirement benefit plan (income) expense	(93)	(138)
Postretirement plan contributions	(171)	(182)
Share-based compensation	80	56
Provision for income taxes	213	216
Cash paid during the year for income taxes	(231)	(270)
Changes in operating assets and liabilities, excluding the effects of acquisitions:
Receivables	62	185
Inventories	(310)	(188)
Contract and other deferred assets	(132)	(48)
Accounts payable	21	(113)
Contract liabilities	83	(23)
Current compensation and benefits	(231)	(207)
All other operating activities – net	(130)	(218)
Cash from (used for) operating activities	458	344
Cash flows – investing activities
Additions to property, plant and equipment and internal-use software	(278)	(238)
Purchases of businesses, net of cash acquired	(2,293)	(279)
Purchases of investments	(19)	(28)
All other investing activities – net	(24)	(84)
Cash from (used for) investing activities	(2,615)	(630)
Cash flows – financing activities
Net increase (decrease) in borrowings (maturities of 90 days or less)	(1)	1
Newly issued debt, net of debt issuance costs (maturities longer than 90 days)	1,152	1,493
Repayments and other reductions (maturities longer than 90 days)	(1,012)	(261)
Dividends paid to stockholders	(32)	(32)
Repurchase of common stock	(300)	(100)
Proceeds from stock issued under employee benefit plans	10	21
Taxes paid related to net share settlement of equity awards	(21)	(33)
All other financing activities – net	(12)	(15)
Cash from (used for) financing activities	(215)	1,075
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash	(35)	84
Increase (decrease) in cash, cash equivalents, and restricted cash	(2,407)	873
Cash, cash equivalents, and restricted cash at beginning of year	4,515	2,893
Cash, cash equivalents, and restricted cash at end of period	2,108	3,766
Supplemental disclosure of cash flows information
Cash paid during the year for interest	(280)	(260)
Non-cash investing activities
Acquired but unpaid property, plant, and equipment	$ 102	$ 90

Condensed Consolidated Statements of Financial Position (Unaudited) - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Statement of Financial Position [Abstract]
Cash, cash equivalents, and restricted cash	$ 2,105	$ 4,512
Receivables – net of allowances of $102 and $103	3,881	3,955
Inventories	2,483	2,234
Contract and other deferred assets	1,235	1,073
All other current assets	793	726
Current assets	10,497	12,501
Property, plant, and equipment – net	3,146	3,092
Goodwill	15,095	13,489
Other intangible assets – net	1,894	1,130
Deferred income taxes	4,359	4,491
All other non-current assets	2,254	2,205
Total assets	37,246	36,906
Short-term borrowings	2	508
Accounts payable	3,231	3,250
Contract liabilities	2,200	2,095
Current compensation and benefits	1,439	1,666
All other current liabilities	1,429	1,587
Current liabilities	8,302	9,105
Long-term borrowings	10,091	9,495
Non-current compensation and benefits	5,186	5,453
Deferred income taxes	315	193
All other non-current liabilities	2,133	2,061
Total liabilities	26,027	26,307
Commitments and contingencies
Redeemable noncontrolling interests	229	209
Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 459,470,464 shares issued as of June 30, 2026; 458,844,209 shares issued as of December 31, 2025	5	5
Treasury stock, at cost, 7,785,199 shares as of June 30, 2026 and 3,107,626 shares as of December 31, 2025	(525)	(225)
Additional paid-in capital	6,776	6,707
Retained earnings	6,199	5,281
Accumulated other comprehensive income (loss) – net	(1,480)	(1,388)
Total equity attributable to GE HealthCare	10,975	10,379
Noncontrolling interests	14	11
Total equity	10,989	10,390
Total liabilities, redeemable noncontrolling interests, and equity	$ 37,246	$ 36,906